Similar articles

• [IFG and IGT in Europe and America: the present and prospective].

  Tsujii S, Kuzuya H. Tsujii S, et al. Nihon Rinsho. 2005 Feb;63 Suppl 2:27-33. Nihon Rinsho. 2005. PMID: 15779341 Review. Japanese. No abstract available.
• [Effect of impaired fasting glucose and impaired glucose tolerance on the progression of diabetic macroangiopathy].

  Igarashi M, Tominaga M. Igarashi M, et al. Nihon Rinsho. 2005 Feb;63 Suppl 2:55-60. Nihon Rinsho. 2005. PMID: 15779345 Review. Japanese. No abstract available.
• [Definition and diagnosis of IFG, IGT and borderline type].

  Kawazu S. Kawazu S. Nihon Rinsho. 2005 Feb;63 Suppl 2:43-8. Nihon Rinsho. 2005. PMID: 15779343 Review. Japanese. No abstract available.
• Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.

  Tutuncuoğlu P, Saraç F, Saygili F, Ozgen AG, Yilmaz C, Tüzün M. Tutuncuoğlu P, et al. Acta Diabetol. 2008 Sep;45(3):151-6. doi: 10.1007/s00592-008-0034-y. Epub 2008 May 22. Acta Diabetol. 2008. PMID: 18496644
• Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.

  Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L. Gerstein HC, et al. Diabetes Res Clin Pract. 2007 Dec;78(3):305-12. doi: 10.1016/j.diabres.2007.05.004. Epub 2007 Jun 29. Diabetes Res Clin Pract. 2007. PMID: 17601626 Review.